REVBIO, INC.
Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging Patients
Based based in Lowell, MA, REVBIO, INC. works in national institute on aging.
Profile
"RevBio, Inc. is a pioneering health company dedicated to revolutionizing medicine through the development of a biocompatible bone adhesive. Their flagship product, Tetranite, is an injectable, self-setting biomaterial that bonds bone to bone and bone to metal in wet environments. Tetranite is currently under FDA review for various medical applications in oral, craniofacial, orthopedic, and neurosurgical fields. This innovative adhesive biodegrades over time, promoting new bone growth and ultimately improving patient outcomes by reducing procedure complexity, enabling minimally invasive surgeries, and enhancing recovery times. RevBio's groundbreaking technology has the potential to transform the medical industry by streamlining procedures, enhancing patient care, and reducing overall healthcare costs."
REVBIO, INC. is positioned in national institute on aging, a segment that rewards a clear, focused offering.
Lowell, MA is where the company is located.
It is recorded at the SBIR/STTR stage.
It has disclosed roughly $414K in funding.
| Sector | National Institute on Aging |
|---|---|
| Headquarters | Lowell, MA |
| Country | United States |
| Stage | SBIR/STTR |
| Total funding | $413,833 |
Website: revbio.com
Create a free account